Evidence map›Paper›PMID 39523682›Full record

ReviewImmunological reviews2025

Role of inflammasomes and neuroinflammation in epilepsy.

Ava Hollis, John R Lukens

Abstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Immune-mediated excitotoxicity in brain disorders.Nature reviews. Immunology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Increased expression of proinflammatory cytokines in the cerebrospinal fluid of patients with a history of electrical status epilepticus in sleep.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ava HollisCenter for Brain Immunology and Glia (BIG), Department of Neuroscience, University of Virginia, Charlottesville, Virginia, USA.
John R LukensCenter for Brain Immunology and Glia (BIG), Department of Neuroscience, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-6795-0866

Funding

Making a case for CASS4 in Alzheimer's diseaseR01AG087406 · NIA · UNIVERSITY OF VIRGINIA · PI John R Lukens · 2024 to 2026
$1.7M
CLEC7A in microglia biology and Alzheimer's diseaseRF1AG078684 · NIA · UNIVERSITY OF VIRGINIA · PI LUKENS, JOHN R · 2023 to 2023
$1.6M
Role of the SYK-CARD9 signaling axis in Alzheimer's diseaseR01AG071996 · NIA · UNIVERSITY OF VIRGINIA · PI LUKENS, JOHN R · 2024 to 2025
$1.1M
Alzheimer's Association ADSF-21-816651Cure Alzheimer's FundNIA NIH HHS R01 AG071996NIA NIH HHS R01 AG087406NIA NIH HHS RF1 AG078684Owens Family FoundationThe National Institutes of Health/National Institute of Aging R01AG071996The National Institutes of Health/National Institute of Aging R01AG087406The National Institutes of Health/National Institute of Aging RF1AG078684
6 · The paper itself

Abstract

Epilepsy is a brain disorder characterized by recurrent seizures, which are brief episodes of abnormal electrical activity in the brain and involuntary movement that can lead to physical injury and loss of consciousness. Seizures are canonically accompanied by increased inflammatory cytokine production that promotes neuroinflammation, brain pathology, and seizure propagation. Understanding the source of pro-inflammatory cytokines which promote seizure pathogenesis could be a gateway to precision epilepsy drug design. This review discusses the inflammasome in epilepsy including its role in seizure propagation and negative impacts on brain health. The inflammasome is a multiprotein complex that coordinates IL-1β and IL-18 production in response to tissue damage, cellular stress, and infection. Clinical evidence for inflammasome signaling in epileptogenesis is reviewed followed by a discussion of emerging strategies to modulate inflammasome activity in epilepsy.

Indexed as

BrainEpilepsyInflammasomesNeuroinflammatory DiseasesAnimalsCytokinesHumansInflammation MediatorsInterleukin-1betaSignal TransductionCytokinesInflammasomesInflammation MediatorsInterleukin-1betaepilepsyGasdermin DIL‐18IL‐1 family cytokinesIL‐1βinflammasomesneuroinflammationNOD‐like receptorseizure

Identifiers

PMID39523682
PMCPMC11744240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.